Prognostication refinement in NPM1‐mutated acute myeloid leukemia stratified by FLT3‐ITD status with different induction doses of cytarabine

OBJECTIVE: We aimed to retrospectively discern the heterogeneity of outcomes from clinicopathological characteristics and next‐generation sequencing (NGS) data in adult patients with NPM1‐mutated (NPM1 (mut)) acute myeloid leukemia (AML) induced with standard‐dose (SD, 100–200 mg/m(2)) and intermedi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Biao, Hua, Xiaoying, Zhang, Jihong, Gu, Weiying, Li, Haiqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166952/
https://www.ncbi.nlm.nih.gov/pubmed/36808479
http://dx.doi.org/10.1002/cam4.5704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166952/
https://www.ncbi.nlm.nih.gov/pubmed/36808479
http://dx.doi.org/10.1002/cam4.5704

Ejemplares similares